Search results
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 1 day ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant that was dominant ...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 3 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
3 Things You Need to Know If You Buy Novavax Today
Motley Fool via Yahoo Finance· 4 days agoImage source: Getty Images. 1. Novavax's new partnership may supercharge its revenue growth, but don't expect pandemic-level sales Novavax's vaccine...
Arbutus, Novavax See Activist Investor Action
Barrons.com· 1 day agoMcElhaugh...directors. In the recent 13D amendment, filed on May 20, Shah said it withdrew the proxy statement because Novavax’s “recent announcement of...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 3 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 6 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 2 days agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 4 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 7 days agoElsewhere, though the company's combination COVID/flu vaccine does look exciting, if it fails to...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
